U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

National Collaborating Centre for Mental Health (UK). Antenatal and Postnatal Mental Health: Clinical Management and Service Guidance: Updated edition. Leicester (UK): British Psychological Society; 2014 Dec. (NICE Clinical Guidelines, No. 192.)

  • April 2018: Footnotes and cautions have been added and amended by NICE to link to the MHRA's latest advice and resources on sodium valproate. Sodium valproate must not be used in pregnancy, and only used in girls and women when there is no alternative and a pregnancy prevention plan is in place. This is because of the risk of malformations and developmental abnormalities in the baby.

April 2018: Footnotes and cautions have been added and amended by NICE to link to the MHRA's latest advice and resources on sodium valproate. Sodium valproate must not be used in pregnancy, and only used in girls and women when there is no alternative and a pregnancy prevention plan is in place. This is because of the risk of malformations and developmental abnormalities in the baby.

Cover of Antenatal and Postnatal Mental Health

Antenatal and Postnatal Mental Health: Clinical Management and Service Guidance: Updated edition.

Show details

APPENDIX 242007 HEALTH ECONOMICS EVIDENCE ON MOTHER AND BABY UNITS

BOATH2003

Boath E, Major K, Cox J. When the cradle falls II: the cost-effectiveness of treating postnatal depression in a psychiatric day hospital compared with routine primary care. Journal of Affective Disorders. 2003;74:159–166. [PubMed: 12706517]

Study, year and countryIntervention detailsStudy population
Study design – data source
Study typeCosts: description and values
Outcomes: description and values
Results: cost effectivenessComments
Internal validity
(Yes/No/NA)
Industry support
Boath et al, 2003 UKIntervention:
Specialised psychiatric parent and baby day hospital unit (PBDU)

Comparator:
Routine primary care (RPC) provided by GPs and health visitors with occasional referrals into secondary care
Women with a baby aged between 6 weeks and 1 year, EPDS score ≥ 12 anda diagnosis of major or minor depressive disorder according to RDC; exclusion criteria: puerperal psychosis, schizophrenia, history of drug or alcohol abuse, women not speaking English

Data source for effect-size measures and resource use: prospective cohort study N = 30 in each arm
Cost-effectiveness analysisCosts:
Healthcare costs:
Staff: GPs, health visitors, CPNs, mental health resource centre, PBDU
Inpatient and day care Capital costs and equipment of PBDU

Antidepressant medication Patient costs: transport, childcare Patient time losses: employment, housework, leisure

Total costs (referring to 30 women per arm):
PBDU group: £46,211
RPC group: £18,973
ΔC: £27,238, p < 0.001

Primary outcome:
Number of women successfully treated; recovery defined as no longer fulfilling RDC for major or minor depressive disorder

PBDU group: 21 women successfully treated

RPC group:
7 women successfully treated
ΔE = 14, p < 0.001
ICER of PBDU versus RPC: £1,945 per successfully treated woman

Cost-effectiveness ratio of RPC: £2,710 per successfully treated woman.

Authors' conclusion: PBDU more cost effective than RPC

Results sensitive to exclusion of costs associated with non-significantly different resource use, that is, medication and GP/health visitor costs
  • Perspective: societal
  • Currency: UK £
  • Cost year: 1992/93
  • Discounting: 6% for capital costs
  • Time horizon: 6 months
  • Outcome measures collected by interviews; direct and indirect cost estimates based on resource-use data derived from structured interviews, self-report scales, and retrospective analysis of case-notes
  • Validity score: 20/5/10

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this page (50K)
  • PDF version of this title (8.9M)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...